Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 654,912 shares of the company's stock in a transaction that occurred on Monday, April 21st. The shares were acquired at an average cost of $0.32 per share, for a total transaction of $209,571.84. Following the completion of the transaction, the chief executive officer now directly owns 4,770,214 shares of the company's stock, valued at $1,526,468.48. The trade was a 15.91 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.
Grigorios Siokas also recently made the following trade(s):
- On Monday, March 3rd, Grigorios Siokas purchased 132,572 shares of Cosmos Health stock. The shares were bought at an average cost of $0.49 per share, for a total transaction of $64,960.28.
- On Monday, February 24th, Grigorios Siokas acquired 354,296 shares of Cosmos Health stock. The shares were bought at an average cost of $0.56 per share, with a total value of $198,405.76.
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The stock was bought at an average cost of $0.66 per share, with a total value of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas purchased 38,900 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.77 per share, for a total transaction of $29,953.00.
Cosmos Health Stock Up 13.4 %
Cosmos Health stock opened at $0.36 on Wednesday. Cosmos Health Inc. has a one year low of $0.28 and a one year high of $1.58. The stock has a fifty day moving average of $0.46 and a 200 day moving average of $0.64. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44. The stock has a market cap of $8.37 million, a PE ratio of -0.15 and a beta of 5.50.
Cosmos Health (NASDAQ:COSM - Get Free Report) last released its quarterly earnings results on Tuesday, April 15th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.01. Cosmos Health had a negative net margin of 36.39% and a negative return on equity of 9.39%. The firm had revenue of $14.22 million during the quarter, compared to analyst estimates of $14.50 million. As a group, sell-side analysts predict that Cosmos Health Inc. will post -0.78 EPS for the current year.
Institutional Trading of Cosmos Health
A hedge fund recently raised its stake in Cosmos Health stock. Geode Capital Management LLC grew its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 29.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 193,432 shares of the company's stock after acquiring an additional 43,704 shares during the period. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 12.61% of the stock is owned by institutional investors and hedge funds.
About Cosmos Health
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Read More

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.